Imbrium Therapeutics
Clinical trials sponsored by Imbrium Therapeutics, explained in plain language.
-
New pill shows promise in cutting heavy drinking days
Disease control CompletedThis study tested an experimental drug called sunobinop to see if it could help people with moderate to severe alcohol use disorder drink less. 209 adults who wanted treatment and had frequent heavy drinking days took either the drug or a placebo. The main goal was to see if the …
Phase: PHASE2 • Sponsor: Imbrium Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New drug V117957 tested for painful bladder condition
Symptom relief CompletedThis early-stage study tested a drug called V117957 in 47 women with interstitial cystitis, a condition that causes bladder pain and discomfort. The goal was to see if the drug is safe and can reduce pain compared to a placebo. Participants rated their worst bladder pain each day…
Phase: PHASE1 • Sponsor: Imbrium Therapeutics • Aim: Symptom relief
Last updated May 26, 2026 12:07 UTC